Lee VG - Search Results

1

Venous smooth muscle contains vasoconstrictor ETB-like receptors.

Moreland S, McMullen DM, Delaney CL, Lee VG, Hunt JT. Moreland S, et al. Among authors: lee vg. Biochem Biophys Res Commun. 1992 Apr 15;184(1):100-6. doi: 10.1016/0006-291x(92)91163-k. Biochem Biophys Res Commun. 1992. PMID: 1314581

2

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.

Kimball SD, Floyd DM, Das J, Hunt JT, Krapcho J, Rovnyak G, Duff KJ, Lee VG, Moquin RV, Turk CF, et al. Kimball SD, et al. Among authors: lee vg. J Med Chem. 1992 Feb 21;35(4):780-93. doi: 10.1021/jm00082a020. J Med Chem. 1992. PMID: 1311765

3

Minimum requirements for inhibition of smooth-muscle myosin light-chain kinase by synthetic peptides.

Hunt JT, Floyd DM, Lee VG, Little DK, Moreland S. Hunt JT, et al. Among authors: lee vg. Biochem J. 1989 Jan 1;257(1):73-8. doi: 10.1042/bj2570073. Biochem J. 1989. PMID: 2920029 Free PMC article.

4

Hydroxyamino acid specificity of smooth muscle myosin light chain kinase.

Pearson RB, Floyd DM, Hunt JT, Lee VG, Kemp BE. Pearson RB, et al. Among authors: lee vg. Arch Biochem Biophys. 1988 Jan;260(1):37-44. doi: 10.1016/0003-9861(88)90421-3. Arch Biochem Biophys. 1988. PMID: 3341750

5

The receptor binding affinity of monocyclic [Ala3,Xaa11]endothelin-1 analogs correlates with inducible helix length.

Andersen NH, Harris SM, Lee VG, Liu EC, Moreland S, Hunt JT. Andersen NH, et al. Among authors: lee vg. Bioorg Med Chem. 1995 Feb;3(2):113-24. doi: 10.1016/0968-0896(95)00005-2. Bioorg Med Chem. 1995. PMID: 7796045

6

Structure-activity studies of endothelin leading to novel peptide ETA antagonists.

Hunt JT, Lee VG, McMullen D, Liu EC, Bolgar M, Delaney CL, Festin SM, Floyd DM, Hedberg A, Natarajan S, et al. Hunt JT, et al. Among authors: lee vg. Bioorg Med Chem. 1993 Jul;1(1):59-65. doi: 10.1016/s0968-0896(00)82103-3. Bioorg Med Chem. 1993. PMID: 8081838

7

1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil.

Kimball SD, Hunt JT, Barrish JC, Das J, Floyd DM, Lago MW, Lee VG, Spergel SH, Moreland S, Hedberg SA, et al. Kimball SD, et al. Among authors: lee vg. Bioorg Med Chem. 1993 Oct;1(4):285-307. doi: 10.1016/s0968-0896(00)82134-3. Bioorg Med Chem. 1993. PMID: 8081860

8

Control of peptide disulfide regioisomer formation by mixed cysteine-penicillamine bridges. Application to endothelin-1.

Hunt JT, Lee VG, Liu EC, Moreland S, McMullen D, Webb ML, Bolgar M. Hunt JT, et al. Among authors: lee vg. Int J Pept Protein Res. 1993 Sep;42(3):249-58. doi: 10.1111/j.1399-3011.1993.tb00139.x. Int J Pept Protein Res. 1993. PMID: 8225780

9

Potent, cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase.

Hunt JT, Lee VG, Leftheris K, Seizinger B, Carboni J, Mabus J, Ricca C, Yan N, Manne V. Hunt JT, et al. Among authors: lee vg. J Med Chem. 1996 Jan 19;39(2):353-8. doi: 10.1021/jm9507284. J Med Chem. 1996. PMID: 8558502

10

Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308).

Murugesan N, Gu Z, Stein PD, Bisaha S, Spergel S, Girotra R, Lee VG, Lloyd J, Misra RN, Schmidt J, Mathur A, Stratton L, Kelly YF, Bird E, Waldron T, Liu EC, Zhang R, Lee H, Serafino R, Abboa-Offei B, Mathers P, Giancarli M, Seymour AA, Webb ML, Hunt JT, et al. Murugesan N, et al. Among authors: lee h, lee vg. J Med Chem. 1998 Dec 17;41(26):5198-218. doi: 10.1021/jm970872k. J Med Chem. 1998. PMID: 9857090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters